Using Managed Access Programmes to better manage post-trial treatment access
Managed Access Programmes offer patients an alternate path to treatments that have the potential to change or alter their lives. They are an invaluable resource when considering treatment access for unlicensed medicine. Read more today from Almac’s Industry professional and Unlicensed Medicines Services Manager, Margaret Radford.
View Resource
